Here, we investigated the role of the immune system in the expression of FOXD3-AS1 in glioma (Wu et al., 2019; Sun et al., 2020; Li et al., 2021b; Li et al., 2021a). This evidence concerns the gene FOXD3 and central nervous system cancer.